N-PORT filing recap · December 2025
What did Hillman Value Fund buy in December 2025?
Reported stock-position changes between this filing and the previous one. These are Hillman Value Fund's own holdings, not the firm's.
Stock value
$93.71M
Positions
39
Estimated turnover
20.3%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Period in review
Hillman Value Fund opened a new position in Akamai Technologies while exiting a prior Akamai stake. It also substantially added to DuPont De Nemours, CarMax, and Fiserv. Trims were widespread, with moderate reductions across United Parcel Service, US Bancorp, Warner Bros. Discovery, Bristol-Myers Squibb, CVS Health, Biogen, Nucor, Taiwan Semiconductor Manufacturing, GSK, and others, while Walt Disney, West Pharmaceutical Services, Hershey, UnitedHealth Group, Microsoft, Zimmer Biomet, and Baxter International saw slight decreases.